Actualizado 25/11/2011 18:53
- Comunicado -

European Commission Approves Labelling Update for REYATAZ® (atazanavir sulfate) in Pregnant Women Living With HIV (y 2)

(6) European Medicines Agency. REYATAZ: EPAR Summary for the public. Updated March 2009. Available at http://www.ema.europa.eu/ema/index.jsp?c... 000494/human_med_001035.jsp&mid=WC0b01ac058001d124 Accessed November 2011 [http://www.ema.europa.eu/ema/index.jsp?c... ]

(7) The Body, Switching Antiretroviral Therapy. Available at http://www.thebody.com/content/art38572..... Accessed 25 May 2010 [http://www.thebody.com/content/art38572.... ]

(8) Johnson, M et al. Gender-based differences in antiretroviral-naive patients treated with ritonavir-boosted protease inhibitors: CASTLE study 96-Week Results. Presented at EACS 2009.

(9) UNAIDS. AIDS Epidemic Updated, 2009. Available at http://www.unaids.org/en/media/unaids/co... . Accessed November 2011.

(10) UNAIDS. AIDS Epidemic Updated, 2007. Available at http://data.unaids.org/pub/epislides/200.... Accessed December 2010.

(11) Haile-Selassie, H. et al. HIV infection in Central and Eastern European pregnant women living in the UK/Ireland: data from national surveillance 1992-2007. University College London, Institute of Child Health Institute of Child Health. BHIVA 2009

CONTACT: Annie Simond, office: +33-01-58-83-65-66, or Joanna Ritter,office: +33-01-58-83-65-09, both for Bristol-Myers Squibb Company

Comunicados

Si quieres mejorar el posicionamiento online de tu marca, ahora puedes publicar tus notas de prensa o comunicados de empresa en la sección de Comunicados de europa press

Si necesitas asesoramiento en comunicación, redacción de tus notas de prensa o ampliar la difusión de tu comunicado más allá de la página web de europa press, ponte en contacto con nosotros en comunicacion@europapress.es o en el teléfono 913592600